Sort
51,593 grants matching “hepatitis”
Neurocognitive Effects of HCV, HIV, and Drug Use
$425,650University Of California San Diego · R01 · FY2004 · DA
Texas National HIV Behavioral Surveillance
$425,639Sharon K Melville · Texas State Dept Of Health Services · U1B · FY2011 · PS
Animal Core
$425,635Hidekazu Tsukamoto · University Of Southern California · P50 · FY2021 · AA
Role of ABCG5 and ABCG8 in Sterol Metabolism
$425,622Helen H. Hobbs · Ut Southwestern Medical Center · R37 · FY2010 · HL
Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes
$425,569Stephen J Pandol · Cedars-Sinai Medical Center · U01 · FY2018 · DK
PROJECT 4: Targeting Methionine Adenosyltransferases in Liver Metastasis
$425,539Shelly Chi-Loo Lu · Cedars-Sinai Medical Center · P01 · FY2023 · CA
CLINICAL AND BIOLOGICAL BASIS OF 18F-FDG PET IN CANCER
$425,466Sloan-Kettering Institute For Cancer Res · R01 · FY2001 · CA
Novel roles of copper in adaptive responses to hypoxia
$425,455Michael J Petris · University Of Missouri-Columbia · R01 · FY2023 · DK
Impact of HCV Therapy on CNS Outcomes
$425,405Ajay R Bharti · University Of California, San Diego · R01 · FY2019 · DA
Evaluating the impact of genetic ancestry and HIV on cirrhosis progression and response to statin therapy among a diverse multi-ethnic cohort of patients with cirrhosis
$425,398David Seth Goldberg · University Of Miami School Of Medicine · U01 · FY2022 · DK
Studies on Pancreatic Hormones
$425,358University Of Chicago · R01 · FY2003 · DK
Taking aim at HBV eradication using novel NRTIs and Capsid effectors
$425,333Stefan G Sarafianos · Emory University · R01 · FY2017 · AI
Substrate Cycling in Energy Metabolism
$425,328University Of Texas Medical Br Galveston · R01 · FY2005 · DK
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment
$425,312Bernard Mark Evers · University Of Kentucky · R01 · FY2018 · CA
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment
$425,312Bernard Mark Evers · University Of Kentucky · R01 · FY2020 · CA
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment
$425,312Bernard Mark Evers · University Of Kentucky · R01 · FY2017 · CA
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment
$425,312Bernard Mark Evers · University Of Kentucky · R01 · FY2021 · CA
Analysis and Modulation of Virus-Host Interaction in Animal Models
$425,259Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
Liver Cancer Therapy by MiR-22 and Its Inducers
$425,256Yu-Jui Yvonne Wan · University Of California At Davis · R01 · FY2023 · CA
REGULATION OF NET HEPATIC GLUCOSE UPTAKE IN VIVO
$425,252Vanderbilt University · R01 · FY2004 · DK
LncRNA as a New Mediator of Bile Acid Homeostasis
$425,252Li Wang · University Of Connecticut Storrs · R01 · FY2015 · DK
How IL-10R blockade can resolve persistent viral infections
$425,250Matthias G. Von Herrath · La Jolla Institute For Immunology · R01 · FY2007 · AI
P13K/PTEN/Akt signaling and the genesis of cancer
$425,203Nissim Hay · University Of Illinois At Chicago · R01 · FY2020 · CA
P13K/PTEN/Akt signaling and the genesis of cancer
$425,203Nissim Hay · University Of Illinois At Chicago · R01 · FY2021 · CA
Role of phospho UBC9 in alcohol-associated liver disease
$425,179Maria Lauda Tomasi · Cedars-Sinai Medical Center · R01 · FY2025 · AA